Logotype for The Scotts Miracle-Gro Company

The Scotts Miracle-Gro (SMG) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for The Scotts Miracle-Gro Company

Q4 2024 earnings summary

16 Jan, 2026

Executive summary

  • Fiscal 2024 marked a pivotal turnaround, achieving all key objectives: improved margins, strong free cash flow, and strategic progress in Hawthorne, with a shift from crisis management to growth-focused strategy.

  • U.S. Consumer segment net sales grew 6% year-over-year, driven by new listings, promotions, and expanded shelf space.

  • Hawthorne segment loss improved 70% year-over-year, returning to positive EBITDA after two years of losses, with a focus on proprietary brands.

  • Strategic investments in marketing and innovation supported sales and brand health, while cost-reduction initiatives and operational improvements continued.

  • Maintained dividend without issuing new shares and established a foundation for a three-year growth plan.

Financial highlights

  • Full-year net sales were $3.55–$3.6 billion, flat year-over-year; U.S. Consumer sales up 6%, Hawthorne down 37%.

  • Adjusted EBITDA grew 20% to $539 million, with reported adjusted EBITDA at $510.1 million including $29 million in one-time charges.

  • Adjusted net income for FY24 was $132.0 million ($2.29 per share), up from $68.1 million ($1.21 per share) last year.

  • Free cash flow exceeded $1 billion over two years, with $580–$584 million generated in 2024 and inventories reduced below $600 million.

  • Interest expense decreased to $158.8 million, and SG&A was $559.0 million, 15.7% of net sales.

Outlook and guidance

  • Fiscal 2025 guidance: adjusted EBITDA of $570–$590 million (up 6–9%), U.S. consumer sales growth of 2%, and $20 million EBITDA from Hawthorne.

  • Gross margin expected to approach 30% in 2025, with at least $40 million in incremental brand investments.

  • Free cash flow projected at $250 million, CapEx at $100 million, and leverage targeted in the low 4x range by year-end.

  • Three-year targets: 3% annual growth, $700 million EBITDA, mid-30s% gross margin, and leverage near 3x by 2027.

  • Continued efforts to support an eventual separation of the Hawthorne business when timing is appropriate.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more